REGN7508: Clinical Trials

3 trials of REGN7508, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Recruiting 1

Follow REGN7508: new trials by email Literature Review of REGN7508 trials Research Report on REGN7508

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
REGN7508, REGN9933, Apixaban - Atrial Fibrillation (AF)
Phase 2RecruitingRegeneron Pharmaceuticals12002025-10-202026-11-05
A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC)
REGN9933, REGN7508, Placebo - Venous Thromboembolism
Phase 2CompletedRegeneron Pharmaceuticals1952024-09-202026-04-13
A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants
REGN7508, Enoxaparin - Venous Thromboembolism
Phase 2CompletedRegeneron Pharmaceuticals1792024-06-272026-05-27

Conditions studied

Venous Thromboembolism (2)  ·  Atrial Fibrillation (1)  ·  Hemorrhage (1)  ·  Stroke (1)  ·  Thrombosis (1)

Sponsors

Regeneron Pharmaceuticals (3)

Countries

Bulgaria (2)  ·  Canada (2)  ·  United States (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Hungary (1)  ·  Israel (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Poland (1)  ·  Romania (1)  ·  United Kingdom (1)

Results publications

PMID 41218619

NIH funding

2023 (2)